Development of a New Type of Prolonged Release Hydrocodone Formulation Based on Egalet® ADPREM Technology Using In Vivo–In Vitro Correlation

A novel abuse deterrent, prolonged release tablet formulation of Hydrocodone for once-daily dosing has been developed, based on the novel proprietary Egalet® ADPREM technology. The tablet is an injection molded polymer system consisting of an erodible matrix in which the Active Pharmaceutical Ingred...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemmingsen, Pernille H., Haahr, Anne-Mette, Gunnergaard, Christine, Cardot, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857038/
https://www.ncbi.nlm.nih.gov/pubmed/24310426
http://dx.doi.org/10.3390/pharmaceutics3010073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857038/
https://www.ncbi.nlm.nih.gov/pubmed/24310426
http://dx.doi.org/10.3390/pharmaceutics3010073

Ejemplares similares